What is the generic name?

EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE

What is the Trade Name for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE?

efavirenz, emtricitabine and tenofovir disoproxil fumarate

What are the Indications for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE?

• 1 INDICATIONS AND USAGE Efavirenz, Emtricitabine and Tenofovir disoproxil fumarate tablet is indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg. Efavirenz, emtricitabine and tenofovir disoproxil fumarate tablet is a three-drug combination of efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor, and emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF), both HIV-1 nucleoside analog reverse transcriptase inhibitors, and is indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg. ( 1 )

References: https://open.fda.gov/